After analyzing 218 patients with MDS with ring sideroblasts ≥5%, investigators suggested SF3B1-unmutated MDS-RS as a distinct entity to the mutant counterpart characterized by increased prevalence of MDS with excess blasts, complex karyotype, lower peripheral blood counts, and TP53 mutation. This evidence concerns the gene TP53 and myelodysplastic syndrome.